World Health Organization site
Skip Navigation Links

Main
Note: This record shows only the 20 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: REBEC
Last refreshed on: 29 April 2013
Main ID:  RBR-8m444q
Date of registration: 09/03/2012
Primary sponsor: Universidade Federal do Rio Grande do Norte - Natal, RN, Brazil
Public title: Evaluation of anesthesia in cardiac surgery patients
Scientific title: Evaluation of the analgesic efficacy of general and spinal anesthesia with morphine associated ropivacaine in patients who underwent surgery type coronary artery bypass grafting
Date of first enrolment: 15/03/2012
Target sample size: 58
Recruitment status: not yet recruiting
URL:  http://www.ensaiosclinicos.gov.br/rg/RBR-8m444q/
Study type: 
Study design:  Therapeutic, parallel, two arms, single-blind, randomized, clinical trial  
Countries of recruitment
Brazil
Contacts
Name: Valdecy  Pinheiro
Address:  Av. Senador Salgado Filho, SN, Departamento de Enfermagem, Campus Central da UFRN 59200-000 Natal Brazil
Telephone: 84 99939807
Email: valdecy63@gmail.com
Affiliation:  Universidade Federal do Rio Grande do Norte
Name: Valdecy  Pinheiro
Address:  Av. Senador Salgado Filho, SN, Departamento de Enfermagem, Campus Central da UFRN 59200-000 Natal Brazil
Telephone: 84 99939807
Email: valdecy63@gmail.com
Affiliation:  Universidade Federal do Rio Grande do Norte
Key inclusion & exclusion criteria
Inclusion criteria: Assessment of the physical status;
Anesthetic risk classification according to the American Society of Anesthesiologists (ASA) ASA II and III;
The indication of coronary artery bypass grafting;
Verbal skills and understanding appropriate to participate in the interview; - No pain preoperatively.

Exclusion criteria: Manifestation of the patient and / or guardian's desire not to continue in the study;
Present severe postoperative complications such as respiratory and heart failure, valvular heart disease associated procedures and emergencies, reoperation;
Other disorders pre-operative treatment with heparin, since it may affect patients' responses to questions about pain.


Age minimum: 40Y
Age maximum: 80Y
Gender: -
Health Condition(s) or Problem(s) studied
Chronic ischemic heart disease, unspecified
I25.9
Intervention(s)
In the experimental group, composed of 30 subjects, subarachnoid puncture is performed with patient in sitting position, after infiltration before skin and subcutaneous tissue with lidocaine 2% without epinephrine, 3 to 5 ml. After the puncture, held-to spinal median L3 or L4, needle number 25 to 27, the first morphine injection at a dose of 400mg; second injection of 0.6 ml ropivacaine, 0.5% hyperbaric with 3ml doubly distilled water. After 15 minutes, it will elevate the lower limbs. Then begins the induction of general anesthesia with Diprivan A (diprifusor) of 40mg/ml, sulfetanil and pancuronium 0.1 mg / kp, maintenance diprivam around 20 to 40 mg / ml and muscle relaxation with pancuronium 0.1 mg / kg 1 / 1 hour with 25% of the initial dose, followed by tracheal intubation with low-volume cuff and low pressure. Positioning of the tracheal tube is confirmed by auscultation and capnography in the presence of wave.
In the active control group, composed of 28 subjects, will perform general anesthesia alone, following the same pattern as the experimental group without spinal puncture.
Primary Outcome(s)
Improvement of the pain intensity, measured by the visual analogue scale (VAS), with scores ranging from 0 to 10 where 0 indicates no pain and 10 to give maximum.
Improves the quality of painmeasured by the McGill pain scale that assesses the painful experience in the dimensions: sensory, affective and evaluative and is based on words that patients select to describe their pain.
Reduction of the location of pain, measured by direct question to the respondent.
Secondary Outcome(s)
Reduced time to wake analyzed by checking the record time in the patient. Increased time for the request of analgesic analyzed by checking the record time in the patient. Absence or diminution of thoracic drains analyzed by visualization after the intervention. Absence or reduction of hyperemia before removal of drains by viewing the time of chest removal of the drain. Reduction of pain intensity in the removal of drains, measured by visual analog scale. Decrease in analgesic consumption measured by the amount of drugs consumed by the patient
Secondary ID(s)
186-05
Source(s) of Monetary Support
Promater Hospital Geral - Natal, RN, Brazil
Universidade Federal do Rio Grande do Norte - Natal, RN, Brazil
Secondary Sponsor(s)
Promater Hospital Geral - Natal, RN, Brazil
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.1 - Version history